Table 2 of Churchill, Mol Vis 2005; 11:66-70.


Table 2. Summary of results

Out of 26 Peters' anomaly cases, there were seven who showed no sequence changes in the CYP1B1 gene (two were familial and five sporadic). Four previously identified DNA polymorphisms were confirmed in both Peters' anomaly and the normal controls. A novel sequence change was identified in a simplex case of Peters' anomaly at -16 IVS1. This is not predicted to influence transcription. Seven Peters' anomaly cases manifest a compound heterozygous change at codon 432 replacing valine with leucine on one allele and arginine on the other. The "Genetics" column identifies whether the case is simples (S), familial (F), or a control. The GenBank accession number for the sequence is U03688 (OMIM 601771).

                          Genotype
                             and
            Fragment      position
          ------------     (codon/      Amino acid              Ethnic
Patient   1A   3A   3B   nucleotide)      change     Genetics   origin
-------   --   --   --   -----------   -----------   --------   -------
  C1                *    449 GAT/GAC   No effect     Control    UK
  C2      *    *    *    -13 C/T 48    No effect     Control    UK
                         CGG/GGG 432   Arg>Arg/Gly
                         GTG/CTG 449   Val>Val/Leu
                         GAT/GAC       No effect
  P1A          *         432 CTG/CTG   Val>Leu/Leu   F          UK
  P1B          *         432 CTG/CTG   Val>Leu/Leu   F          UK
  P2A     *    *    *    -13 C/T 48    No effect     F          USA
                         CGG/GGG 432   Arg>Arg/Gly
                         CTG/CTG 449   Val>Leu/Leu
                         GAC/GAC       No effect
  P2B          *    *    432 CTG/CTG   Val>Leu/Leu   F          USA
                         449 GAC/GAC   No effect
  P3A          *    *    432 CTG/CGG   Val>Arg/Leu   F          UK
                         449 GAC/GAC   No effect
  P3B          *    *    432 CTG/CGG   Val>Arg/Leu   F          UK
                         449 GAC/GAC   No effect
  P4A     *         *    -13 C/T 48    No effect     F          UK
                         CGG/GGG 449   Arg>Arg/Gly
                         GAT/GAC       No effect
  P5      *    *    *    -13 T/T 48    No effect     S          UK
                         GGG/GGG 432   Arg>Gly
                         CTG/CGG       Val>Arg/Leu
  P6      *              -13 C/T 48    No effect     S          UK
                         CGG/GGG       Arg>Arg/Gly
  P7      *              -13 C/T 48    No effect     S          Asia
                         CGG/GGG       Arg>Arg/Gly
  P8A     *              -13 C/T 48    No effect     S          USA
                         CGG/GGG       Arg>Arg/Gly
  P9      *         *    -16 C/T 449   No effect     S          USA
                         GAT/GAC       No effect
  P10     *    *         -13 C/T 48    No effect     S          Ireland
                         CGG/GGG 432   Arg>Arg/Gly
                         CTG/CGG       Val>Arg/Leu
  P11               *    -13 C/T 48    No effect     S          UK
                         CGG/GGG 449   Arg>Arg/Gly
                         GAT/GAC       No effect
  P12          *    *    432 CTG/CGG   Val>Arg/Leu   S          Asia
                         449 GAC/GAC   No effect
  P13          *         432 CTG/CGG   Val>Arg/Leu   S          UK
  P14          *         432 CTG/CGG   Val>Arg/Leu   S          USA
  P15          *         432 CTG/CTG   Val>Leu/Leu   S          UK
  P16               *    449 GAT/GAC   No effect     S          Ireland

Churchill, Mol Vis 2005; 11:66-70 <http://www.molvis.org/molvis/v11/a7/>
©2005 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535